Companion diagnostics

Jul 24, 2026

For decades, the diagnosis and monitoring of cancer have depended heavily on tissue biopsy, a procedure that involves surgically or percutaneously removing a piece of tumor for pathological examination. While tissue biopsy remains the diagnostic gold standard, it is invasive, carries procedural risk, cannot always ...

Jul 15, 2026

For most of medical history, treating disease meant casting a wide net. Chemotherapy attacked every fast-dividing cell it could find, healthy or cancerous. Broad-spectrum drugs treated symptoms without ever asking why a particular patient's biology behaved the way it did. That era is ending. Targeted therapeutics, ...

Mar 25, 2026

Molecular diagnostics is a rapidly advancing field within laboratory medicine that applies molecular biology techniques to detect and quantify specific DNA or RNA sequences. By enabling earlier detection, greater diagnostic accuracy, and more informed clinical decision-making, these technologies have become indispe...

Mar 11, 2026

The landscape of modern medicine is undergoing a profound shift from a "one-size-fits-all" approach to a model that is deeply personalized and data-driven. At the heart of this transformation is the concept of precision medicine, which seeks to tailor medical treatment to the individual characteristics of each pati...

Feb 05, 2026

GE HealthCare Announced the U.S. FDA 510(k) Clearance and CE Mark for Allia Moveo and marks first Global Installation, Advancing Precision Care in the Interventional Suite On February 02, 2026, GE HealthCare announced that Allia™ Moveo received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark...

Sep 25, 2025

Medtronic Secured FDA Approval for the Altaviva™ Device, Delivering a Simpler Experience in Treating Urge Urinary Incontinence  On September 19, 2025, Medtronic plc, a global leader in healthcare technology, announced that it had received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ de...

May 01, 2025

Medtronic Received FDA Approval for Smallest-Diameter, Lumenless Defibrillation Lead, the Omniasecure™ Lead and Published Investigational Clinical Study Results, Offering New Therapy Option for Heart Rhythm Disorders  On April 25, 2025, Medtronic plc., a global leader in healthcare technology, received U.S....

Jan 23, 2025

Tempus Announced the National Launch of the FDA-Approved xT CDx Test  On January 15, 2025, Tempus AI, Inc., a technology company driving the use of AI to advance precision medicine and improve patient care, announced the nationwide launch of its FDA-approved, NGS-based in vitro diagnostic device, xT CDx. Th...

Nov 09, 2023

SIBIONICS Received CE Mark for Its Ground-breaking GS1 Continuous Glucose Monitoring System On November 01, 2023, SIBIONICS, the world's third-largest Continuous Glucose Monitoring System (CGM) brand, received the CE Mark for its revolutionary GS1 CGM.  This significant milestone marks a momentous achiev...

Dec 22, 2022

Medtronic Announced First Patient Enrolment for Hugo™ Robotic-Assisted Surgery System in US Clinical Trial On December 15, 2022, Medtronic, a global healthcare technology leader, announced that the first patient was enrolled in the Expand URO US clinical trial for the Hugo™ robotic-assisted surgery...